Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bakris

Showing results (571-580 of 738) with videos related to

Pageof 74
Sort By:
American Journal of Hypertension|June 13, 2020
Association of Arterial Stiffness With Kidney Function Among Adults Without Chronic Kidney DiseaseSeiji Itano, Yuichiro Yano, Hajime Nagasu, et al.
Journal of Internal Medicine|November 29, 2014
Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studiesM Böhm, H Schumacher, R E Schmieder, et al.
American Journal of Nephrology|June 7, 2014
Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methylMelanie P Chin, Scott A Reisman, George L Bakris, et al.
International Journal of Cardiology|January 20, 2012
Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trialC Barrett Bowling, Paul W Sanders, Richard M Allman, et al.
Kidney International|November 11, 2022
A prespecified exploratory analysis from FIDELITY examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetesGeorge L Bakris, Luis M Ruilope, Stefan D Anker, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 25, 2008
Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP)Obidiugwu Kenrik Duru, Suying Li, Claudine Jurkovitz, et al.
Kidney International|April 29, 2023
Effects of newer kidney protective agents on kidney endpoints provide implications for future clinical trialsHiddo J L Heerspink, Niels Jongs, Brendon L Neuen, et al.
International Journal of Cardiology|January 13, 2009
Oral potassium supplement use and outcomes in chronic heart failure: a propensity-matched studyO James Ekundayo, Chris Adamopoulos, Mustafa I Ahmed, et al.
International Journal of Cardiology|June 9, 2009
Mild hyperkalemia and outcomes in chronic heart failure: a propensity matched studyMustafa I Ahmed, O James Ekundayo, Marjan Mujib, et al.
Lancet (London, England)|March 14, 2015
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trialFaiez Zannad, Christopher P Cannon, William C Cushman, et al.
Pageof 74

Showing results (571-580 of 738) with videos related to

Sort By:
Pageof 74
American Journal of Hypertension|June 13, 2020
Association of Arterial Stiffness With Kidney Function Among Adults Without Chronic Kidney DiseaseSeiji Itano, Yuichiro Yano, Hajime Nagasu, et al.
Journal of Internal Medicine|November 29, 2014
Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studiesM Böhm, H Schumacher, R E Schmieder, et al.
American Journal of Nephrology|June 7, 2014
Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methylMelanie P Chin, Scott A Reisman, George L Bakris, et al.
International Journal of Cardiology|January 20, 2012
Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trialC Barrett Bowling, Paul W Sanders, Richard M Allman, et al.
Kidney International|November 11, 2022
A prespecified exploratory analysis from FIDELITY examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetesGeorge L Bakris, Luis M Ruilope, Stefan D Anker, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 25, 2008
Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP)Obidiugwu Kenrik Duru, Suying Li, Claudine Jurkovitz, et al.
Kidney International|April 29, 2023
Effects of newer kidney protective agents on kidney endpoints provide implications for future clinical trialsHiddo J L Heerspink, Niels Jongs, Brendon L Neuen, et al.
International Journal of Cardiology|January 13, 2009
Oral potassium supplement use and outcomes in chronic heart failure: a propensity-matched studyO James Ekundayo, Chris Adamopoulos, Mustafa I Ahmed, et al.
International Journal of Cardiology|June 9, 2009
Mild hyperkalemia and outcomes in chronic heart failure: a propensity matched studyMustafa I Ahmed, O James Ekundayo, Marjan Mujib, et al.
Lancet (London, England)|March 14, 2015
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trialFaiez Zannad, Christopher P Cannon, William C Cushman, et al.
Pageof 74